Search Legislation

The Health Protection (Coronavirus, International Travel and Operator Liability) (England) (Amendment) (No. 18) Regulations 2021

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As made)
 Help about opening options

Opening Options

Status:

This is the original version (as it was originally made). This item of legislation is currently only available in its original format.

Amendments to regulation 3A

This section has no associated Explanatory Memorandum

4.  In regulation 3A (interpretation of Part)(1)—

(a)in paragraph (1), after sub-paragraph (b), insert—

(c)a reference to a country does not include a reference to the overseas territories and dependencies of that country unless otherwise stated.;

(b)in paragraph (2)—

(i)in the definition of “authorised vaccine”, in sub-paragraph (c), for the words from “would be authorised” to the end, substitute—

(i)would be authorised as provided for in paragraph (a)(i) or (ii) if the doses were received in the United Kingdom, or

(ii)are listed in lines 10, 11 or 13 of the Guidance Document “Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process” published by the World Health Organisation on 11th November 2021(2), and authorised or certified in a relevant country listed in paragraph (4);;

(ii)in the definition of “NHS COVID pass”—

(aa)after “records”, insert “available”;

(bb)after “NHS.uk or”, insert “in”;

(iii)after the definition of “NHS Wales”, insert—

North American Certificate” means, in relation to a State listed in the table in paragraph (2B), the certificate identified in the corresponding row of the second column of that table;;

(iv)after the definition of “NHS Wales”, insert—

Regulation (EU) 2021/953” means Regulation (EU) 2021/953 of the European Parliament and of the Council of 14 June 2021 on a framework for the issuance, verification and acceptance of interoperable COVID-19 vaccination, test and recovery certificates (EU Digital COVID Certificate) to facilitate free movement during the COVID-19 pandemic(3).

(c)after paragraph (2), insert—

(2A) The following countries and territories are approved third countries or territories for the purposes of this Part—

  • Albania

  • Armenia

  • Faroe Islands

  • Israel

  • Morocco

  • North Macedonia

  • Panama

  • Turkey

  • Ukraine.

(2B) The table referred to in the definition of “North American Certificate” in paragraph (2) is—

StateCertificate Name
CaliforniaDigital COVID-19 Vaccine Record
New YorkExcelsior Pass Plus
Washington StateWA Verify;

(d)in paragraph (3), in the opening words, after “paragraph (2)” insert “except in the definition of “North American Certificate””;

(e)in paragraph (4), in the list of countries and territories, at the appropriate places insert entries for—

  • Belarus

  • Bolivia

  • Democratic Republic of the Congo

  • Dominican Republic

  • Ecuador

  • Laos

  • Libya

  • Malawi

  • Mozambique

  • Samoa

  • Senegal

  • Vanuatu

  • Zambia

  • Zimbabwe..

(1)

Regulations 3A to 3K were inserted by S.I. 2021/1107.

(2)

A copy may be downloaded from https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_11Nov2021.pdf. A hard copy may be obtained from the Department of Health and Social Care, 39 Victoria Street, London, SW1H 0EU.

(3)

OJ L 211, 15.6.21, p.1.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

Explanatory Memorandum

Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as made version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources